A regulatory strategy defines the pathway that brings a medical device to market, from qualification and classification through to the planning of all activities required to demonstrate compliance. Building on this foundation, the clinical strategy determines how the evidence required to support the device is generated and documented.
The integration of regulatory and clinical strategies is a key factor in guiding both development and business decisions, with a direct impact on timelines, investments, risk management, and market positioning.
To explore the relationship between these two areas, Complife Academy, in collaboration with GBA Key2Compliance, is organizing a free webinar focused on how the intended purpose and claims influence the Clinical Evaluation, the assessment of available evidence, and decisions regarding potential clinical investigations and study design.
Date
30 June, 2026
Time
11:00-12:00 CET
Registration Deadline
25 June, 2026
Typology
Live Streaming
Language
English
Pricing
Free
